Simple rapid method for quantification of antiretrovirals by liquid chromatography - Tandem mass-spectrometry

Clinical Biochemistry

Volumn 35, Issue 2, 2002, Pages 99-103

  Volosov, Andrew ^a   Alexander, Christopher ^c   Ting, Lillian ^c   Soldin, Steven J ^a,b  

^a CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^b GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^c BRITISH COLUMBIA CENTRE FOR EXCELLENCE IN HIV AIDS   (Canada)

Author keywords

AIDS; Anti HIV; Antiretrovirals; Chromatography; HIV; LC; MS; Tandem mass spectrometry

Indexed keywords

ABACAVIR; ACETONITRILE; AMMONIUM ACETATE; AMPRENAVIR; ANTIRETROVIRUS AGENT; CIMETIDINE; DELAVIRDINE; DIDANOSINE; EFAVIRENZ; INDINAVIR; LAMIVUDINE; LOPINAVIR; METHANOL; NELFINAVIR; NEVIRAPINE; RITONAVIR; SAQUINAVIR; STAVUDINE; ZALCITABINE; ZIDOVUDINE;

ACCURACY; ARTICLE; CALIBRATION; CENTRIFUGATION; DRUG COMPETITION; DRUG DETERMINATION; ELUTION; EXTRACTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PRECIPITATION; PRIORITY JOURNAL; QUALITY CONTROL; TANDEM MASS SPECTROMETRY;

ANTI-HIV AGENTS; CALIBRATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG EVALUATION; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; OXAZINES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; STAVUDINE; ZIDOVUDINE;

EID: 0036225704     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9120(02)00286-2     Document Type: Article

References (20)

1. Antiretroviral therapy for HIV infection: Promises, and problems
2. Recent advances in the management of human immunodeficiency virus infection
3. Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: A prospective cohort study
4. Dual protease inhibitor therapy in HIV-infected patients: Pharmacological rationale, and clinical benefits
5. Pharmacokinetic-pharmacodynamic consequences, and clinical relevance of cytochrome P450 3A inhibition
6. Interactions among drugs for HIV, and opportunistic infections
7. Therapeutic drug monitoring of antiretrovirals in human immunodeficiency virus infection
8. Variability in trough plasma saquinavir concentrations in HIV patients
9. The extent of non-adherence in a large AIDS clinical trial using plasma dideozynucleoside concentrations as a marker
10. Adherence to protease inhibitor therapy, and outcomes in patients with HIV infection
11. Combination therapy with amprenavir, abacavir, and efavirenz in human immunodeficiency virus (HIV)-infected patients failing a protease-inhibitor regimen: Pharmacokinetic drug interactions, and antiviral activity
12. Critical issues int herapeutic drug monitoring of antiretroviral drugs
13. Sensitive, and rapid method for the simultaneous quantification of the HIV-protease inhibitors indinavir, nelfinavir, ritonavir, and saquinavir in human plasma by reversed-phase liquid chromatography
14. Drug monitoring of antiretroviral therapy for HIV-I infection: Method validation, and results of a pilot study
15. Simultaneous determination of the HIV protease inhibitors indinavir, amprenavir, saquinavir, ritonavir, and nelfinavir in human plasma by high-performance liquid chromatography
16. Therapeutic drug monitoring of antiretrovirals: Simultaneous determination of five protease inhibitors, and three nonnucleoside transcriptase inhibitors in human plasma by a rapid high-performance liquid chromatography-mass spectrometry assay
17. Analysis of anti-HIV nucleoside inhibitors by capillary electrophoresis-electrospray ionization mass spectromerty
18. Simultaneous determination of the five HIV-protease inhibitors: Amprenavir, indinavir, nelfinavir, ritonavir, and saquinavir in human plasma by solid-phase extraction, and column liquid chromatography
19. Effect of heating human seraat a temperature necessary to deactivate human immunodeficiency virus on measurement of free phenytoin, free valproic acid, and free carbamazepine concentrations
20. Simultaneous simple, and fast quantification of three major immunosuppressants by liquid chromatography-tandem mass-spectrometry